Open Access iconOpen Access

ARTICLE

crossmark

Apatinib reduces liver cancer cell multidrug resistance by modulating NF-κB signaling pathway

XIAOXIAO HE1, XUEQING ZHOU2, JINPENG ZHANG2, MINGFEI ZHANG2, DANHONG ZENG2, HENG ZHANG1, SHUCAI YANG2,*

1 Department of Gastroenterology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
2 Department of Clinical Laboratory, Pingshan Hospital, Southern Medical University (Pingshan District People’s Hospital of Shenzhen), Shenzhen, 518118, China

* Corresponding Author: SHUCAI YANG. Email: email

TSP_BIOCELL_52625.pdf

  • 920

    View

  • 266

    Download

  • 0

    Like

Share Link